Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001416083-13-000007
Filing Date
2013-05-13
Accepted
2013-05-13 17:25:04
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q catalent-20130331x10q.htm 10-Q 1989369
8 EXHIBIT catalent-20130331xex322.htm EX-32.2 4698
9 EXHIBIT catalent-20130331xex321.htm EX-32.1 4937
10 EXHIBIT catalent-20130331xex312.htm EX-31.2 8587
11 EXHIBIT catalent-20130331xex311.htm EX-31.1 8465
12 EXHIBIT a13965130v5_activex-catale.htm EX-99.1 16036
  Complete submission text file 0001416083-13-000007.txt   16451961

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ck0001416083-20130331.xml EX-101.INS 3524430
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001416083-20130331.xsd EX-101.SCH 82621
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001416083-20130331_cal.xml EX-101.CAL 110426
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001416083-20130331_def.xml EX-101.DEF 270543
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001416083-20130331_lab.xml EX-101.LAB 768156
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001416083-20130331_pre.xml EX-101.PRE 467457
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent Pharma Solutions, Inc. (Filer) CIK: 0001416083 (see all company filings)

EIN.: 133523163 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-147871 | Film No.: 13838465
SIC: 2834 Pharmaceutical Preparations